Objectives: Despite the fact that the bla OXA-48 and bla NDM-1 genes have successfully disseminated among Klebsiella pneumoniae isolates worldwide, outbreaks remain unidentified in Iran. Here we examined the molecular epidemiology of 96 carbapenem-resistant K. pneumoniae recovered from an Iranian hospital.
Introduction
Carbapenemase-producing Klebsiella pneumoniae (CPKP) are increasingly reported worldwide and represent a major clinical concern.
1,2 Infections due to CPKP are associated with high rates of morbidity and mortality as a result of limited therapeutic options. 3, 4 The most clinically important carbapenemase genes in CPKP are Ambler class A (KPC type), class B (NDM, VIM and IMP types) and class D (OXA-48-like). 5 The bla NDM-1 gene has been detected on different transferable plasmids (IncA/C, IncFII, IncN or untypeable plasmids). 6 The bla OXA-48 gene was also carried by various plasmid types, including IncL/M, IncN, IncA/C or untypeable. 3 The most important reservoir of NDM-1-producing bacteria is the Indian subcontinent and the Balkan region, 7 while Turkey and the wider Mediterranean basin can be considered the main reservoirs of OXA-48-like producers. 4, [8] [9] [10] NDM-1-and OXA-48-producing K. pneumoniae have shown a remarkable ability to spread and in some settings have established high-level endemicity. Hospital outbreaks by NDM-1-or OXA-48-producing K. pneumoniae have been described in Turkey 11 and, more recently, in the UK, 12 Spain, 13 China 3 and the Netherlands. 14 Iran is located in the Middle East with many of the neighbouring countries having an endemic situation with regards to OXA-48 and NDM-1. The population exchange between countries such as Turkey, Iraq, Pakistan and Afghanistan is high. On one side, there is population transfer from Pakistan and Afghanistan to Iran and on the other side, pilgrimage and tourism of Iranians to Iraq and Turkey.
The first report of CPKP in Iran was an imipenem-resistant strain isolated from the urine culture of a 52-year-old male resident in Tehran province in 2011. 15 More recently, in 2014, six NDM-1-producing K. pneumoniae were isolated from inpatients at a hospital in Isfahan, Iran. 16 However, there is hitherto no information about the STs of CPKP that have circulated in Iran.
The aim of this study was to investigate the prevalence of carbapenemase and ESBL resistance determinants in CPKP from Iran, analyse the clonal relatedness of patient isolates and, finally, to characterize plasmids carried in such strains. 
Materials and methods

Bacterial isolates
From September 2014 to January 2016, a total of 96 non-duplicate clinical isolates of carbapenem-resistant K. pneumoniae were collected from an 800-bed university hospital in Isfahan, Iran. Isolates were identified by standard biochemical tests and use of API 20E (bioMérieux, Marcy-l'Étoile, France). No ethical approval was obtained for using the clinical samples since they were collected during routine bacteriological analyses in our hospital.
Antimicrobial susceptibility testing and phenotypic assays
Antimicrobial susceptibility testing was performed using the disc diffusion method. The MICs of imipenem, meropenem and ertapenem antibiotics (Liofilchem, Italy) were determined by gradient test strips based on CLSI guidelines. 17 The MIC of colistin was determined by Etest strips (bioMérieux). EUCAST breakpoints were used for interpretation. 18 Escherichia coli ATCC 25922 was used as the quality control strain for antimicrobial susceptibility testing. Following CLSI recommendations, the modified Hodge test (MHT) was used as a phenotypic method to detect carbapenemase-producing strains with ertapenem discs. 17 
Molecular detection of genes encoding carbapenemases and ESBLs
Plasmid DNA was extracted using the GeneAll Exprep Plasmid kit (GeneAll Biotechnology, Seoul, Korea). PCR assays were carried out for detection of bla KPC , bla GES , bla VIM , bla IMP , bla NDM , bla OXA-48 , bla CTX-M , bla TEM and bla SHV genes using a set of specific primers as previously described. 15, 19 The primers used for the detection of SHV b-lactamase amplify solely the ESBL genes and not the chromosomally encoded SHV-1. The DNA amplicons were sequenced using an ABI Capillary System (Macrogen Research, Seoul, Korea).
Molecular typing methods
The clonal relatedness among the 96 CPKP isolates was characterized by the PFGE method. Genomic DNAs were digested with XbaI restriction endonuclease (Fermentas) and DNA bands electroporated using a CHEF-DRIII system (Bio-Rad Laboratories), with a linear pulse time ramped from 5 to 30 s for 20 h at 14 C and constant voltage of 6 V/cm. Isolates that exhibited similarity cut-off 80% were considered a pulsotype. 20 MLST was performed according to the protocol described on the K. pneumoniae MLST website (http://www.pasteur.fr/recherche/geno pole/PF8/mlst/Kpneumoniae.html).
Plasmid analysis and conjugation experiments
Experiments focused on the potential for conjugational transfer of carbapenem resistance. Filter mating assays were carried out, with E. coli K12 [F # lac ! Nal (r)] as the recipient strain. Isolates ES39, ES49 and E69, which harboured only the bla NDM-1 or bla OXA-48 gene, and isolates ES94 and ES132, which harboured the bla OXA-48 and bla NDM-1 genes, were selected and used. Transconjugants were selected on MacConkey agar plates containing 32 mg/L nalidixic acid and 1 mg/L meropenem. 21 The bla NDM-1 and bla OXA-48 genes were identified by PCR amplification.
Plasmid DNA was isolated from both donor and transconjugant strains using the GeneAll Exprep Plasmid kit. The plasmid bands were observed on 0.7% agarose gels. The extracted plasmids of these isolates were digested by HindIII restriction enzyme (Fermentas) and restriction patterns were compared. Plasmid incompatibility was determined by a PCR-based replicon typing scheme, as previously described. 22 
GenBank accession numbers
The nucleotide sequences of the bla NDM-1 and bla OXA-48 genes were assigned GenBank accession numbers KX467530 and KX246861, respectively.
Results
Bacterial isolates
From September 2014 to January 2016, a total of 96 isolates of carbapenem-resistant K. pneumoniae were collected from 96 patients. Seventy-four isolates (77%) were isolated from ICU wards, whereas the remaining isolates were recovered from other wards. The isolates were predominantly collected from tracheal secretions (49/96; 51.0%) and urine (24/96; 25%). Other sites of isolation included wound secretions (6/96; 6.2%), blood (4/96; 4.2%), catheter (4/96; 4.2%), CSF (4/96; 4.2%), sputum (1/96; 1%), nasal cavity (1/96; 1%), bronchoalveolar lavage (BAL) (1/96; 1%), throat (1/96; 1%) and pleural fluid (1/96; 1%) ( Figure 1 ).
Antimicrobial susceptibility testing
Overall, all of the isolates were resistant to at least three classes of antibiotic and they were considered MDR. The rates of resistance to imipenem, meropenem and ertapenem among isolates were 87.5% (84/96), 95.8% (92/96) and 100% (96/96), respectively. All isolates were resistant to ertapenem, with MICs ranging from 4 to 8 mg/L. The isolates exhibited various levels of resistance to imipenem and meropenem. The rate of isolates exhibiting resistance to colistin was 9.4% (9/96), with MICs ranging from 6 to 64 mg/L. It should be noted that the gradient test method can both underestimate and overestimate colistin resistance. The MICs of carbapenem agents for all isolates are shown in Table 1 . The percentages of resistance to other antimicrobial agents were as follows: amikacin 52.1% (50/96); gentamicin 84.4% (81/96); aztreonam 97.9% (94/96); ciprofloxacin 97.9% (94/96); and fosfomycin 10.4% (10/96). All K. pneumoniae isolates demonstrated resistance to ceftazidime, cefotaxime and cefepime whereas all of them were susceptible to tigecycline.
Seventy-seven of the 96 isolates (80.2%) were phenotypically carbapenemase positive in terms of the ertapenem-MHT method.
Carbapenemase and ESBL genes
Overall, 56 out of the 96 CPKP (58.3%) harboured only the bla OXA-48 gene and 6 (6.3%) carried only the bla NDM-1 gene. Thirty-four (35.4%) of these isolates co-produced the bla NDM-1 and bla OXA-48 genes (Table 1) . Other carbapenemases genes, including bla KPC , bla VIM and bla IMP , were not detected among isolates. The genotyping results of the ESBL-producing isolates obtained by PCR amplification of CTX-M, TEM and SHV genes are shown in Table 1 . Among the 96 isolates, 94 (97.9%) ESBL producers were observed. Of the 94 ESBL producers, only ES138 harboured solely the CTX-M-15 gene and only ES122 and ES133 the SHV ESBL gene, whereas 93.6% (88/94) of isolates included all three genes together. In addition, 3.2% (3/94) of isolates (ES131, ES132 and ES134) included the CTX-M-15 and SHV genes together.
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Clonal relatedness of CPKP isolates
PFGE revealed that 87 of the 96 CPKP could be categorized into seven pulsotypes: A (47 isolates), B (29 isolates), C (2 isolates), D (3 isolates), E (2 isolates), F (2 isolates) and G (2 isolates), whereas 9 isolates appeared to be singletons ( Figure 1 ). 
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MLST demonstrated that each of the K. pneumoniae PFGE pulsotypes was associated with a unique ST. Strains belonging to pulsotypes A, B, C, E, F and G were assigned to ST11, ST893, ST893, ST147, ST147 and ST915, respectively. ST11 and ST893 were two major STs (Figure 1) , comprising 48 and 31 isolates, respectively.
Plasmid replicon typing and conjugation assays
Plasmid replicon typing revealed that 47 bla OXA-48 -carrying and 10 bla NDM-1 -carrying K. pneumoniae isolates contained plasmid types belonging to IncL/M and IncFII, respectively. In just one isolate of ST11 (ES77), the bla OXA-48 gene was found to be associated with an IncT plasmid. In the other 32 isolates we could not identify the incompatibility group (6 isolates not determined).
Conjugation assays showed that the plasmids carrying bla OXA-48 and bla NDM-1 genes in all five strains were successfully transferred to E. coli K12 as the recipient strain. The antimicrobial resistance profile of the transconjugants is shown in Table 2 . PCR confirmed the presence of the bla OXA-48 and bla NDM-1 genes in the transconjugants; all transconjugants, except Tc-ES49, also harboured bla CTX-M-15 and bla TEM genes.
Plasmid analysis indicated that bla OXA-48 in transconjugants Tc-ES39 and Tc-ES69 was located on 39 kb IncL/M conjugative plasmids (Table 2) ; the two plasmids showed identical profiles after HindIII digestion (data not shown). In Tc-ES49, bla NDM-1 was found on a 50 kb IncFII conjugative plasmid. Transconjugants Tc-ES132 and Tc-ES94 each contained a single plasmid; the two plasmids had distinct restriction profiles (data not shown). Transconjugants Tc-ES132 and Tc-ES94 were only positive for bla OXA-48 , bla CTX-M-15 and bla TEM genes, whereas they were negative for the bla NDM-1 gene. In initial isolates of ES94 and ES132, plasmid gel extraction followed by PCR amplification revealed that the bla OXA-48 gene was harboured on a transferable plasmid of 39 kb belonging to the IncL/M incompatibility group, whereas the bla NDM-1 gene was carried on a non-conjugative plasmid of 4 or 10 kb.
Discussion
This study highlights the finding of CPKP with bla OXA-48 and bla NDM-1 genes together or alone, in a hospital in Isfahan. The cooccurrence of OXA-48-and NDM-1-producing K. pneumoniae has been reported in some Asian and European countries. 1, 3, 23, 24 In this hospital, bla NDM-1 was first isolated in March 2013 16 and the prevalence of bla NDM-1 -producing K. pneumoniae isolates collected at this hospital increased from 12.2% in 2013-14 to 41.7% in 2015-16 (our study). In addition, our previous study in this hospital showed that intestinal carriage rates of NDM-1-and OXA-48-producing Enterobacteriaceae are high, suggesting that NDM-1 and OXA-48 have become endemic. 25 In addition to recent observations in neighbouring countries (Kuwait 26 and Lebanon 9 ), this indicates the emergence of this resistance mechanism in the Middle East.
Analysis of transconjugants revealed that the bla OXA-48 gene, together with bla CTX-M-15 and bla TEM , were carried on 39 kb transferable plasmids belonging to the IncL/M incompatibility group, in accordance with other studies showing that bla OXA-48 was carried by an epidemic plasmid worldwide. 1, 3 Previous studies have reported that the spread of bla NDM-1 is linked to different types of IncA/C, IncF, IncN and untypeable plasmids. 6, 27 We found Tc-ES49 carrying bla NDM-1 in a 50 kb IncFII plasmid (Table 2) . Transferable IncL/M and IncFII plasmids have greatly contributed to the dissemination of antibiotic resistance genes such as bla OXA-48 , bla NDM-1 and bla CTX-M-15 among K. pneumoniae, but they also have the ability to transfer between other enterobacterial species. 6, 28, 29 In the present study, pulsotype A (n " 47) and pulsotype B (n " 29) corresponded to ST11 and ST893, respectively (Figure 1 ). ST11 and ST893 have been circulating in this hospital setting during the period of investigation, indicating two separate outbreaks, with the ICU acting as the epicentre. Interestingly, two clones were overlapping and most isolates were identified in February 2015. Hospital outbreaks linked to CPKP have been previously reported and are likely associated with particular clonal lineages, Solgi et al.
similar to our study. 3, 29 Therefore, it is crucial to identify the clonal relatedness among the CPKP to strengthen the surveillance and reporting system in hospital infection control measures. ST11 (47 pulsotype A and 1 singleton) was the predominant CPKP that disseminated across 10 wards. All ST11 isolates carried the bla OXA-48 gene, whereas six isolates of ST11 co-produced bla OXA-48 and bla NDM-1 genes. ST11 is a single-locus variant of the pandemic ST258 clone and it was considered a high-risk epidemic clone owing to its ability to spread rapidly and disseminate b-lactamases (such as ESBLs and carbapenemases). In the present study, the majority of ST11 isolates carried OXA-48 and CTX-M-15 genes. Previous studies have also identified a high frequency of association between CTX-M-15 and OXA-48 or NDM-1 in ST11 isolates. 1, 3, 6 ST893 (29 pulsotype B and 2 pulsotype C) was the second most common ST in our study and was isolated from patients in six different wards. Overall, co-existence of bla OXA-48 and bla NDM-1 genes among this clone was found to be 77.4% (24/31). The coproduction of these two genes in ST893 accounted for its high resistance to carbapenems (Table 1 ). ST893 has only been reported in China and has not been associated with ESBLs or carbapenemases. 30 In our study, five minor pulsotypes were also observed (C, D, E, F and G). Pulsotype C included the two ST893 isolates. ST147 (pulsotypes E and F) that harboured an IncFII plasmid and was positive for bla NDM-1 and ESBL genes was isolated from four patients on three different wards. Also, two NDM-1-positive ST147 isolates produced OXA-48. The ST147 isolates have been identified in OXA-48 and OXA-204 producers in France 31, 32 and China 3 and also reported in NDM-1 producers in Tunisia 33 and Oman. 34 ST915 (pulsotype G) carried the bla NDM-1 gene, which was isolated from two patients on two different wards. The most remarkable finding from our study is that the ST893 and ST915 clones have not been previously linked with NDM and OXA-48 production and are not clustered with any of the high-risk clones previously associated with these enzymes, which could indicate that the spread of carbapenemases is evolving towards new STs.
In conclusion, a clonal dissemination and outbreak of OXA-48-and NDM-1-producing K. pneumoniae that co-produce ESBLs has been observed. ST11 and ST893 K. pneumoniae were the predominant clones that were associated with the two separate outbreaks and harboured a host narrow-range IncFII plasmid of 50 kb or broad-range IncL/M plasmid of 39 kb. There is no doubt the emergence and spread of NDM-1 and OXA-48 in K. pneumoniae will further limit clinical therapeutic options and threaten the public health of Iran. It is crucial that strict infection control measures should be adopted to control CPKP outbreaks in our clinical settings.
